Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy
L. E. R. Cunha, A. A. Stolet, M. A. Strauch, V. A. R. Pereira, C. H. Dumard, A. M. O. Gomes, P. N. C. Souza, J. G. Fonseca, F. E. Pontes, L. G. R. Meirelles, J. W. M. Albuquerque, C. Q. Sacramento, N. Fintelman-Rodrigues, T. M. Lima, R. G. F. Alvim, , J. L. Silva
This study produces potent equine antibodies against SARS-CoV-2 spike protein with high neutralizing titers, supporting a clinical trial for passive immunization therapy.
bioRxiv · Aug 17, 2020 · PreprintImmunology